RECURRENT HIGH GRADE GLIOMA
Clinical trials for RECURRENT HIGH GRADE GLIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT HIGH GRADE GLIOMA trials appear
Sign up with your email to follow new studies for RECURRENT HIGH GRADE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test 'Trojan Horse' virus to attack deadly recurrent brain cancer
Disease control ENROLLING_BY_INVITATIONThis early-stage study is testing a new treatment for people with aggressive brain tumors (high-grade glioma) that have come back or gotten worse after standard therapy. Doctors inject a specially engineered virus directly into the brain tumor. The virus is designed to infect and…
Matched conditions: RECURRENT HIGH GRADE GLIOMA
Phase: PHASE1, PHASE2 • Sponsor: Beijing Bio-Targeting Therapeutics Technology Co., Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for kids with aggressive brain cancer: experimental stem cell therapy trial opens
Disease control OngoingThis early-stage trial is testing whether a combination of specially prepared stem cells and an immunotherapy drug (nivolumab) can help children and young adults with aggressive brain tumors that have returned after standard treatment. The study involves 12 participants aged 4-26…
Matched conditions: RECURRENT HIGH GRADE GLIOMA
Phase: PHASE1 • Sponsor: University of Florida • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New RNA shot aims to train immune system to fight Kids' tough cancers
Disease control OngoingThis study is testing a new, personalized vaccine made from a patient's own tumor RNA. It aims to teach the immune system to recognize and attack cancer cells in children and young adults whose aggressive brain tumors or bone cancer have come back. The main goals are to see if th…
Matched conditions: RECURRENT HIGH GRADE GLIOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated Mar 18, 2026 18:25 UTC